StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)

Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –

Quest Diagnostics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Quest Diagnostics's pe ratio was 27.5× on Nov 11, 2026, against 22.3× a year earlier. Over the last 5 years it ranged from 8.1× to 27.5×, with a median of 20.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202627.5×+7.0
2025Dec 31, 202520.5×+0.3
2024Dec 31, 202420.1×−0.5
2023Dec 29, 202320.7×+5.3
2022Dec 30, 202215.4×+5.0
2021Dec 31, 202110.4×−4.3
2020Dec 31, 202014.7×−5.3
2019Dec 31, 201920.0×+6.5
2018Dec 31, 201813.5×−7.2
2017Dec 29, 201720.6×+1.1
2016Dec 30, 201619.5×+4.9
2015Dec 31, 201514.6×−4.7
2014Dec 31, 201419.3×+8.4
2013Dec 31, 201310.8×−9.1
2012Dec 31, 201220.0×+4.9
2011Dec 30, 201115.0×+1.7
2010Dec 31, 201013.3×−2.7
2009Dec 31, 200916.0×–

More Quest Diagnostics figures

See a number that looks wrong?